The 100% sensitivity of the ALK RT-PCR Kit for the identification of ALK-positive NSCLC cases, as shown here and by others independently [15,16], supports the use of the test as a screening approach for ALK in newly diagnosed lung cancer. This evidence concerns the gene ALK and non-small cell lung carcinoma.